• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Catalog Number 9-PFO-025
Medical Device Problem Code Patient Device Interaction Problem (4001)
Health Effect - Clinical Code Transient Ischemic Attack (2109)
Date of Event 12/14/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event or Problem Description
It was reported that in an unknown date in 2021, a 25mm amplatzer patent foramen ovale (pfo) occluder was successfully implanted.The patient had a transient ischemic attack (tia) within the last 2 years.A repeat trans-oesophageal echocardiogram (toe) bubble study showed bubbles moving across the defect.On (b)(6) 2023, the patient was brought back to implant another pfo occluder.A 30-25mm amplatzer talisman pfo occluder was attempted.However, before release, bubble study was done, showing bubbles still moving across the left atrium.The device was removed, and a replacement 30mm non-abbott device was implanted.The patient was reported to be discharged.The patient remained hemodynamically stable throughout the procedure.There was no clinically significant delay in procedure and no adverse patient effects.
 
Additional Manufacturer Narrative
An event of residual shunt after implant was reported.No batch number was received, so no lot specific similar complaint review could be performed, and no device history record was reviewed.Information from the field indicated that the cause of the event was due to the defect being undersized.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER PFO OCCLUDER
Common Device Name
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL REG# 2135147
5050 nathan ln n
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key18466715
Report Number2135147-2024-00135
Device Sequence Number3114648
Product Code MLV
UDI-Device Identifier00811806011288
UDI-Public00811806011288
Combination Product (Y/N)N
Initial Reporter CountryAS
PMA/510(K) Number
P120021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/11/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number9-PFO-025
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer Not provided
Supplement Date Received by Manufacturer02/29/2024
Initial Report FDA Received Date01/08/2024
Supplement Report FDA Received Date03/11/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Other; Hospitalization;
Patient Age79 YR
Patient SexFemale
-
-